Title:
PHARMACEUTICAL COMPOSITION COMPRISING CENTANAFADINE
Document Type and Number:
WIPO Patent Application WO/2024/043260
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition comprising (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane (centanafadine) or a pharmaceutically acceptable salt thereof as an active ingredient, and a formulation comprising the pharmaceutical composition, which can be administered once daily.
More Like This:
| WO/2003/077723 | METHODS AND DEVICES FOR DETECTION AND THERAPY OF ATHEROMATOUS PLAQUE |
| JP2000212072 | OPIOID ANALGESIC REGULATED IN RELEASE OF SUBSTANCE |
| WO/1988/007369 | PHARMACEUTICAL FORMULATIONS |
Inventors:
HASEGAWA MASAHIRO (JP)
Application Number:
PCT/JP2023/030255
Publication Date:
February 29, 2024
Filing Date:
August 23, 2023
Export Citation:
Assignee:
OTSUKA PHARMA CO LTD (JP)
International Classes:
A61K9/50; A61K31/403; A61P25/00
Domestic Patent References:
| WO2005039536A1 | 2005-05-06 | |||
| WO2022181625A1 | 2022-09-01 |
Foreign References:
| US20140206740A1 | 2014-07-24 | |||
| EP0202051A2 | 1986-11-20 | |||
| KR101686033B1 | 2016-12-13 |
Attorney, Agent or Firm:
YAMAO, Norihito et al. (JP)
Download PDF: